| Health / Medical Topics |
Technetium Tc 99m Epratuzumab
A radioimmunoconjugate of the humanized IgG1 monoclonal antibody (MoAb) LL2 labeled with Technetium 99m (Tc-99m). Epratuzumab (MoAb LL2) recognizes CD22, a B-lymphocyte-restricted antigen expressed as a cytoplasmic protein in progenitor B cells, and as a cell surface protein in mature B cells. Tc-99m epratuzumab delivers gamma emission Tc-99m directly to B-lymphocyte lineage cells, thereby the agent may be used for diagnostic or treatment purposes. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance being studied as a way to find sentinel lymph nodes in some types of skin cancer and breast cancer. It…
A substance being studied as a way to find certain types of cancer. It contains a radioactive substance called technetium linked to…
A radioconjugate composed of the cytokine interleukin-2 (IL-2) conjugated to the bifunctional chelating agent succinimidyl-6-hydrazinopyridine-3-carboxylate (HYNIC-NHS) and co-ligand tricine and labeled with…
A substance being studied in certain cancer-imaging tests using positron emission tomography (PET). It contains a radioactive substance called technetium, bound to…
A drug used to treat non-small cell lung cancer and urothelial cancer (a type of bladder cancer) that have advanced or spread…
Human TEC wild-type allele is located within 4p12 and is approximately 134 kb in length. This allele, which encodes tyrosine-protein kinase Tec…
